Intravenous alteplase for ischaemic stroke

被引:55
作者
Albers, Gregory W. [1 ]
Olivot, Jean-Marc [1 ]
机构
[1] Stanford Univ, Med Ctr, Dept Neurol & Neurol Sci, Stanford Stroke Ctr, Stanford, CA 94305 USA
关键词
D O I
10.1016/S0140-6736(07)60120-2
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
引用
收藏
页码:249 / 250
页数:2
相关论文
共 14 条
[1]   Intravenous tissue-type plasminogen activator for treatment of acute stroke - The standard treatment with alteplase to reverse stroke (STARS) study [J].
Albers, GW ;
Bates, VE ;
Clark, WM ;
Bell, R ;
Verro, P ;
Hamilton, SA .
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2000, 283 (09) :1145-1150
[2]   Outcome and severe hemorrhagic complications of intravenous thrombolysis with tissue plasminogen activator in very old (≥80 years) stroke patients [J].
Berrouschot, J ;
Röther, J ;
Glahn, J ;
Kucinski, T ;
Fiehler, J ;
Thomalla, G .
STROKE, 2005, 36 (11) :2421-2425
[3]   Generalized efficacy of t-PA for acute stroke - Subgroup analysis of the NINDS t-PA stroke trial [J].
Brott, T ;
Broderick, J ;
Kothari, R ;
ODonoghue, M ;
Barsan, W ;
Tomsick, T ;
Spilker, J ;
Miller, R ;
Sauerbeck, L ;
Farrell, J ;
Kelly, J ;
Perkins, T ;
Miller, R ;
McDonald, T ;
Rorick, M ;
Hickey, C ;
Armitage, J ;
Perry, C ;
Thalinger, K ;
Rhude, R ;
Schill, J ;
Becker, PS ;
Heath, RS ;
Adams, D ;
Reed, R ;
Klei, M ;
Hughes, A ;
Anthony, J ;
Baudendistel, D ;
Zadicoff, C ;
Rymer, M ;
Bettinger, I ;
Laubinger, P ;
Schmerler, M ;
Meiros, G ;
Lyden, P ;
Dunford, J ;
Zivin, J ;
Rapp, K ;
Babcock, T ;
Daum, P ;
Persona, D ;
Brody, M ;
Jackson, C ;
Lewis, S ;
Liss, J ;
Mahdavi, Z ;
Rothrock, J ;
Tom, T ;
Zweifler, R .
STROKE, 1997, 28 (11) :2119-2125
[4]   Asymptomatic hemorrhage after thrombolysis may not be benign - Prognosis by hemorrhage type in the Canadian Alteplase for Stroke Effectiveness Study registry [J].
Dzialowski, Imanuel ;
Pexman, J. H. Warwick ;
Barber, Philip A. ;
Demchuk, Andrew M. ;
Buchan, Alastair M. ;
Hill, Michael D. .
STROKE, 2007, 38 (01) :75-79
[5]   Thrombolysis in stroke patients aged 80 years and older:: Swiss survey of IV thrombolysis [J].
Engelter, ST ;
Reichhart, M ;
Sekoranja, L ;
Georgiadis, D ;
Baumann, A ;
Weder, B ;
Müller, F ;
Lüthy, R ;
Arnold, M ;
Michel, P ;
Mattle, HP ;
Tettenborn, B ;
Hungerbühler, HJ ;
Baumgartner, RW ;
Sztajzel, R ;
Bogousslavsky, J ;
Lyrer, PA .
NEUROLOGY, 2005, 65 (11) :1795-1798
[6]   Hemorrhagic transformation within 36 hours of a cerebral infarct - Relationships with early clinical deterioration and 3-month outcome in the European Cooperative Acute Stroke Study I (ECASS I) cohort [J].
Fiorelli, M ;
Bastianello, S ;
von Kummer, R ;
del Zoppo, GJ ;
Larrue, V ;
Lesaffre, E ;
Ringleb, AP ;
Lorenzano, S ;
Manelfe, C ;
Bozzao, L .
STROKE, 1999, 30 (11) :2280-2284
[7]  
Hacke W, 2004, LANCET, V363, P768
[8]   Thrombolysis for acute ischemic stroke: results of the Canadian Alteplase for Stroke Effectiveness Study [J].
Hill, MD ;
Buchan, AM .
CANADIAN MEDICAL ASSOCIATION JOURNAL, 2005, 172 (10) :1307-1312
[9]   Use of tissue-type plasminogen activator for acute ischemic stroke - The Cleveland area experience [J].
Katzan, IL ;
Furlan, AJ ;
Lloyd, LE ;
Frank, JI ;
Harper, DL ;
Hinchey, JA ;
Hammel, JP ;
Qu, A ;
Sila, CA .
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2000, 283 (09) :1151-1158
[10]   TISSUE-PLASMINOGEN ACTIVATOR FOR ACUTE ISCHEMIC STROKE [J].
MARLER, JR ;
BROTT, T ;
BRODERICK, J ;
KOTHARI, R ;
ODONOGHUE, M ;
BARSAN, W ;
TOMSICK, T ;
SPILKER, J ;
MILLER, R ;
SAUERBECK, L ;
JARRELL, J ;
KELLY, J ;
PERKINS, T ;
MCDONALD, T ;
RORICK, M ;
HICKEY, C ;
ARMITAGE, J ;
PERRY, C ;
THALINGER, K ;
RHUDE, R ;
SCHILL, J ;
BECKER, PS ;
HEATH, RS ;
ADAMS, D ;
REED, R ;
KLEI, M ;
HUGHES, S ;
ANTHONY, J ;
BAUDENDISTEL, D ;
ZADICOFF, C ;
RYMER, M ;
BETTINGER, I ;
LAUBINGER, P ;
SCHMERLER, M ;
MEIROSE, G ;
LYDEN, P ;
RAPP, K ;
BABCOCK, T ;
DAUM, P ;
PERSONA, D ;
BRODY, M ;
JACKSON, C ;
LEWIS, S ;
LISS, J ;
MAHDAVI, Z ;
ROTHROCK, J ;
TOM, T ;
ZWEIFLER, R ;
DUNFORD, J ;
ZIVIN, J .
NEW ENGLAND JOURNAL OF MEDICINE, 1995, 333 (24) :1581-1587